Showing results (101-110 of 259) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 8, 2006
Infectious complications associated with alemtuzumab use for lymphoproliferative disordersStanley I Martin, Francisco M Marty, Karen Fiumara, et al.
Blood|February 7, 2004
Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral bloodJitra Kriangkum, Brian J Taylor, Steven P Treon, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2013
Comparative response assessment by serum immunoglobulin M M-protein and total serum immunoglobulin M after treatment of patients with Waldenström macroglobulinemiaChristina K Tripsas, Christopher J Patterson, Sacha N Uljon, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
Bendamustine therapy in patients with relapsed or refractory Waldenström's macroglobulinemiaSteven P Treon, Christina Hanzis, Christina Tripsas, et al.
Seminars in Oncology|April 30, 2003
Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaDonna Weber, Steven P Treon, Christos Emmanouilides, et al.
Haematologica|June 24, 2021
Natural history of Waldenström macroglobulinemia following acquired resistance to ibrutinib monotherapyJoshua N Gustine, Shayna Sarosiek, Catherine A Flynn, et al.
Clinical Lymphoma|January 8, 2005
Clinical responses to sildenafil in Waldenstrom's macroglobulinemiaSteven P Treon, Olivier Tournilhac, Andrew R Branagan, et al.
British Journal of Haematology|February 18, 2009
Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom MacroglobulinemiaXavier Leleu, Zachary R Hunter, Lian Xu, et al.
British Journal of Haematology|July 4, 2019
CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinibJorge J Castillo, Lian Xu, Joshua N Gustine, et al.
European Journal of Haematology|March 12, 2008
Clinical relevance of soluble HLA class I molecules in Waldenstrom MacroglobulinemiaAnne-Sophie Moreau, Yasmine Sebti, Alain Duhamel, et al.
Pageof 26